Intensive versus standard blood pressure control in SPRINT-eligible participants of ACCORD-BP. Diabetes Care 2017;40:1733-1738

Diabetes Care

Volumn 41, Issue 6, 2018, Pages e84-e85

  Mi, Michael Y ^a   Mukamal, Kenneth J ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; ALBUMINURIA; ALL CAUSE MORTALITY; BLOOD PRESSURE REGULATION; BODY MASS; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; ESTIMATED GLOMERULAR FILTRATION RATE; GLYCEMIC CONTROL; HUMAN; NOTE; PROPENSITY SCORE; RACE; SEX; SMOKING; BLOOD PRESSURE; DRUG EFFECT; HYPERTENSION;

ANTIHYPERTENSIVE AGENT;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; HUMANS; HYPERTENSION;

EID: 85047492969     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc17-2482     Document Type: Note

References (5)

1. Buckley LF, Dixon DL, Wohlford GF IV, Wijesinghe DS, Baker WL, Van Tassell BW. Intensive versus standard blood pressure control in SPRINT-eligible participants of ACCORD-BP. Diabetes Care 2017;40:1733-1738
2. Wright JT Jr, Williamson JD, Whelton PK, et al.; SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 2015;373:2103-2116
3. Cushman WC, Evans GW, Byington RP, et al.; ACCORD Study Group. Effects of intensive bloodpressure control in type 2 diabetes mellitus. N Engl J Med 2010;362:1575-1585
4. D'Agostino RB Sr, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: The Framingham Heart Study. Circulation 2008;117:743-753
5. Stürmer T, Rothman KJ, Avorn J, Glynn RJ. Treatment effects in the presence of unmeasured confounding: Dealing with observations in the tails of the propensity score distribution-a simulation study. AmJ Epidemiol 2010;172:843-854